Enterprise Financial Services Corp Dr Reddys Laboratories LTD Transaction History

Enterprise Financial Services Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$60.19 - $75.29 $21,307 - $26,652	-354 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$57.98 - $73.08 $2,667 - $3,361	46 Added 14.94%	354 $22,000
Q1 2020 May 15, 2020	BUY	$34.75 - $45.85 $3,058 - $4,034	88 Added 40.0%	308 $12,000
Q3 2019 Oct 31, 2019	SELL	$34.82 - $39.26 $1,915 - $2,159	-55 Reduced 20.0%	220 $8,000
Q1 2019 Apr 26, 2019	BUY	$35.77 - $40.57 $357 - $405	10 Added 3.77%	275 $11,000

Q4 2018 Jan 25, 2019	BUY	$31.89 - $38.44 $2,136 - $2,575	67 Added 33.84%	265 $10,000
Q3 2018 Oct 26, 2018	BUY	$29.25 - $36.73 $3,159 - $3,966	108 Added 120.0%	198 $7,000
Q2 2018 Jul 27, 2018	SELL	$28.49 - $35.06 $5,299 - $6,521	-186 Reduced 67.39%	90 $3,000
Q1 2018 Apr 27, 2018	BUY	$31.93 - $39.54 $6,162 - $7,631	193 Added 232.53%	276 $9,000
Q4 2017 Jan 26, 2018	SELL	$34.15 - $37.62 $239 - $263	-7 Reduced 7.78%	83 $3,000
Q3 2017 Oct 27, 2017	BUY	$30.11 - $37.72 $2,709 - $3,394	90	90 $3,000

242

23.6M

25.2K

8.5K

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $12.6B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

Get notified when there are updates to the investment portfolio of Enterprise Financial Services Corp, based on Form 13F filings with the SEC.

Stay updated on Enterprise Financial Services Corp with notifications on news.